109 related articles for article (PubMed ID: 8238918)
1. Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens.
Futscher BW; Blake LL; Gerlach JH; Grogan TM; Dalton WS
Anal Biochem; 1993 Sep; 213(2):414-21. PubMed ID: 8238918
[TBL] [Abstract][Full Text] [Related]
2. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
[TBL] [Abstract][Full Text] [Related]
3. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
[TBL] [Abstract][Full Text] [Related]
4. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
Kobayashi H; Dorai T; Holland JF; Ohnuma T
Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816
[TBL] [Abstract][Full Text] [Related]
5. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
[TBL] [Abstract][Full Text] [Related]
6. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
7. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
[TBL] [Abstract][Full Text] [Related]
8. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
9. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
11. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
12. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells.
Abbaszadegan MR; Futscher BW; Klimecki WT; List A; Dalton WS
Cancer Res; 1994 Sep; 54(17):4676-9. PubMed ID: 8062263
[TBL] [Abstract][Full Text] [Related]
13. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
Tong AW; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Prog Clin Biol Res; 1990; 333():155-64. PubMed ID: 2308979
[TBL] [Abstract][Full Text] [Related]
14. Characterization of canine MDR1 mRNA: its abundance in drug resistant cell lines and in vivo.
Steingold SF; Sharp NJ; McGahan MC; Hughes CS; Dunn SE; Page RL
Anticancer Res; 1998; 18(1A):393-400. PubMed ID: 9568108
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
16. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
[TBL] [Abstract][Full Text] [Related]
17. A competitive nucleic acid sequence-based amplification assay for the quantification of human MDR1 transcript in leukemia cells.
Hayashi T; Kobayashi H; Miyachi H; Ohshima T; Ujiiye T; Kawase M; Hotta T; Takemura Y
Clin Chim Acta; 2004 Apr; 342(1-2):115-26. PubMed ID: 15026272
[TBL] [Abstract][Full Text] [Related]
18. Screening of an annotated compound library for drug activity in a resistant myeloma cell line.
Rickardson L; Fryknäs M; Haglund C; Lövborg H; Nygren P; Gustafsson MG; Isaksson A; Larsson R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):749-58. PubMed ID: 16528529
[TBL] [Abstract][Full Text] [Related]
19. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients.
Krett NL; Pillay S; Moalli PA; Greipp PR; Rosen ST
Cancer Res; 1995 Jul; 55(13):2727-9. PubMed ID: 7796394
[TBL] [Abstract][Full Text] [Related]
20. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]